A lack of HYDROCHLORIC ACID in GASTRIC JUICE despite stimulation of gastric secretion.
A megaloblastic anemia occurring in children but more commonly in later life, characterized by histamine-fast achlorhydria, in which the laboratory and clinical manifestations are based on malabsorption of vitamin B 12 due to a failure of the gastric mucosa to secrete adequate and potent intrinsic factor. (Dorland, 27th ed)
A tumor that secretes VASOACTIVE INTESTINAL PEPTIDE, a neuropeptide that causes VASODILATION; relaxation of smooth muscles; watery DIARRHEA; HYPOKALEMIA; and HYPOCHLORHYDRIA. Vipomas, derived from the pancreatic ISLET CELLS, generally are malignant and can secrete other hormones. In most cases, Vipomas are located in the PANCREAS but can be found in extrapancreatic sites.
Rounded or pyramidal cells of the GASTRIC GLANDS. They secrete HYDROCHLORIC ACID and produce gastric intrinsic factor, a glycoprotein that binds VITAMIN B12.
A family of gastrointestinal peptide hormones that excite the secretion of GASTRIC JUICE. They may also occur in the central nervous system where they are presumed to be neurotransmitters.
A syndrome that is characterized by the triad of severe PEPTIC ULCER, hypersecretion of GASTRIC ACID, and GASTRIN-producing tumors of the PANCREAS or other tissue (GASTRINOMA). This syndrome may be sporadic or be associated with MULTIPLE ENDOCRINE NEOPLASIA TYPE 1.
The liquid secretion of the stomach mucosa consisting of hydrochloric acid (GASTRIC ACID); PEPSINOGENS; INTRINSIC FACTOR; GASTRIN; MUCUS; and the bicarbonate ion (BICARBONATES). (From Best & Taylor's Physiological Basis of Medical Practice, 12th ed, p651)
Hydrochloric acid present in GASTRIC JUICE.
A group of inherited metabolic diseases characterized by the accumulation of excessive amounts of acid mucopolysaccharides, sphingolipids, and/or glycolipids in visceral and mesenchymal cells. Abnormal amounts of sphingolipids or glycolipids are present in neural tissue. INTELLECTUAL DISABILITY and skeletal changes, most notably dysostosis multiplex, occur frequently. (From Joynt, Clinical Neurology, 1992, Ch56, pp36-7)
An organ of digestion situated in the left upper quadrant of the abdomen between the termination of the ESOPHAGUS and the beginning of the DUODENUM.
Lining of the STOMACH, consisting of an inner EPITHELIUM, a middle LAMINA PROPRIA, and an outer MUSCULARIS MUCOSAE. The surface cells produce MUCUS that protects the stomach from attack by digestive acid and enzymes. When the epithelium invaginates into the LAMINA PROPRIA at various region of the stomach (CARDIA; GASTRIC FUNDUS; and PYLORUS), different tubular gastric glands are formed. These glands consist of cells that secrete mucus, enzymes, HYDROCHLORIC ACID, or hormones.

A retrospective study of the usefulness of acid secretory testing. (1/79)

BACKGROUND: Gastric analysis is useful for diagnosing and monitoring the control of hypersecretory conditions and to distinguish appropriate from inappropriate causes of hypergastrinaemia. Pentagastrin, used to measure maximal acid output (MAO), is no longer available in the USA. METHODS: We examined the University of Pennsylvania Health System gastric analysis database, which includes demographic data, study indications, gastric analysis, and serum gastrin and secretin testing results according to referral indications, paying specific attention to discordant basal acid output (BAO) and MAO measurements. RESULTS: One hundred and twenty-four gastric analyses were performed in 103 patients (42 males, mean age 47.5 years, 14 with prior acid-decreasing surgery). Recurrent ulceration or pain unresponsive to antisecretory therapy was the indication in 42 patients. Twelve were hypersecretory, including three each with isolated elevations of BAO or MAO. Hypergastrinaemia was the indication in 35 patients. Five were hypersecretory (four with Zollinger-Ellison syndrome), three had isolated MAO elevations and 16 were hypo- or achlorhydric, indicating appropriate hypergastrinaemia. Of the seven patients with isolated MAO elevations, two had clear benefit from the stimulated portion of the study (four additional patients had equivocal benefit). CONCLUSIONS: Gastrin concentrations cannot be interpreted without knowledge of acid secretory capacity. MAO measurement has a small but significant benefit over measuring BAO alone.  (+info)

Stomachs of mice lacking the gastric H,K-ATPase alpha -subunit have achlorhydria, abnormal parietal cells, and ciliated metaplasia. (2/79)

The H,K-ATPase of the gastric parietal cell is the most critical component of the ion transport system mediating acid secretion in the stomach. To study the requirement of this enzyme in the development, maintenance, and function of the gastric mucosa, we used gene targeting to prepare mice lacking the alpha-subunit. Homozygous mutant (Atp4a(-/-)) mice appeared healthy and exhibited normal systemic electrolyte and acid-base status but were achlorhydric and hypergastrinemic. Immunocytochemical, histological, and ultrastructural analyses of Atp4a(-/-) stomachs revealed the presence of chief cells, demonstrating that the lack of acid secretion does not interfere with their differentiation. Parietal cells were also present in normal numbers, and despite the absence of alpha-subunit mRNA and protein, the beta-subunit was expressed. However, Atp4a(-/-) parietal cells had dilated canaliculi and lacked typical canalicular microvilli and tubulovesicles, and subsets of these cells contained abnormal mitochondria and/or massive glycogen stores. Stomachs of adult Atp4a(-/-) mice exhibited metaplasia, which included the presence of ciliated cells. We conclude that ablation of the H,K-ATPase alpha-subunit causes achlorhydria and hypergastrinemia, severe perturbations in the secretory membranes of the parietal cell, and metaplasia of the gastric mucosa; however, the absence of the pump appears not to perturb parietal cell viability or chief cell differentiation.  (+info)

Acute gastritis with hypochlorhydria: report of 35 cases with long term follow up. (3/79)

BACKGROUND: Between 1976 and 1987, 35 cases of acute gastritis with hypochlorhydria (AGH) were seen in our research laboratory. The aims of this study were to determine the natural history of AGH and the role of Helicobacter pylori in its pathogenesis. METHODS: Archived serum and gastric biopsy samples obtained from AGH subjects were examined for evidence of H pylori colonisation. Twenty eight of 33 (85%) surviving AGH subjects returned a mean of 12 years after AGH for follow up studies, including determination of H pylori antibodies, basal and peak acid output, endoscopy, and gastric biopsies. A matched control group underwent the same studies. RESULTS: Archived material provided strong evidence of new H pylori acquisition in a total of 14 subjects within two months, in 18 within four months, and in 22 within 12 months of recognition of AGH. Prevalence of H pylori colonisation at follow up was 82% (23 of 28) in AGH subjects, significantly (p<0.05) higher than in matched controls (29%). Basal and peak acid output returned to pre-AGH levels in all but two subjects. CONCLUSIONS: One of several possible initial manifestations of H pylori acquisition in adults may be AGH. While H pylori colonisation usually persists, hypochlorhydria resolves in most subjects.  (+info)

Heterogeneity of gastric histology and function in food cobalamin malabsorption: absence of atrophic gastritis and achlorhydria in some patients with severe malabsorption. (4/79)

BACKGROUND: The common but incompletely understood entity of malabsorption of food bound cobalamin is generally presumed to arise from gastritis and/or achlorhydria. AIM: To conduct a systematic comparative examination of gastric histology and function. SUBJECTS: Nineteen volunteers, either healthy or with low cobalamin levels, were prospectively studied without prior knowledge of their absorption or gastric status. METHODS: All subjects underwent prospective assessment of food cobalamin absorption by the egg yolk cobalamin absorption test, endoscopy, histological grading of biopsies from six gastric sites, measurement of gastric secretory function, assay for serum gastrin and antiparietal cell antibodies, and direct tests for Helicobacter pylori infection. RESULTS: The six subjects with severe malabsorption (group I) had worse histological scores overall and lower acid and pepsin secretion than the eight subjects with normal absorption (group III) or the five subjects with mild malabsorption (group II). However, histological findings, and acid and pepsin secretion overlapped considerably between individual subjects in group I and group III. Two distinct subgroups of three subjects each emerged within group I. One subgroup (IA) had severe gastric atrophy and achlorhydria. The other subgroup (IB) had little atrophy and only mild hypochlorhydria; the gastric findings were indistinguishable from those in many subjects with normal absorption. Absorption improved in the two subjects in subgroup IB and in one subject in group II who received antibiotics, along with evidence of clearing of H pylori. None of the subjects in group IA responded to antibiotics. CONCLUSIONS: Food cobalamin malabsorption arises in at least two different gastric settings, one of which involves neither gastric atrophy nor achlorhydria. Malabsorption can respond to antibiotics, but only in some patients. Food cobalamin malabsorption is not always synonymous with atrophic gastritis and achlorhydria, and hypochlorhydria does not always guarantee food cobalamin malabsorption.  (+info)

Hypochlorhydria induced by a proton pump inhibitor leads to intragastric microbial production of acetaldehyde from ethanol. (5/79)

BACKGROUND: Acetaldehyde, produced locally in the digestive tract, has recently been shown to be carcinogenic in humans. AIM: To examine the effect of iatrogenic hypochlorhydria on intragastric acetaldehyde production from ethanol after a moderate dose of alcohol, and to relate the findings to the changes in gastric flora. METHODS: Eight male volunteers ingested ethanol 0.6 g/kg b.w. The pH, acetaldehyde level and microbial counts of the gastric juice were then determined. The experiment was repeated after 7 days of lansoprazole 30 mg b.d. RESULTS: The mean (+/- S.E.M.) pH of the gastric juice was 1.3 +/- 0.06 and 6.1 +/- 0.5 (P < 0.001) before and after lansoprazole, respectively. This was associated with a marked overgrowth of gastric aerobic and anaerobic bacteria (P < 0. 001), by a 2.5-fold (P=0.003) increase in gastric juice acetaldehyde level after ethanol ingestion, and with a positive correlation (r=0. 90, P < 0.001) between gastric juice acetaldehyde concentration and the count of aerobic bacteria. CONCLUSIONS: Treatment with proton pump inhibitors leads to hypochlorhydria, which associates with intragastric overgrowth of aerobic bacteria and microbially-mediated acetaldehyde production from ethanol. Since acetaldehyde is a local carcinogen in the concentrations found in this study, long-term use of gastric acid secretory inhibitors is a potential risk-factor for gastric and cardiac cancers.  (+info)

Assessment of gastric acidity of Japanese subjects over the last 15 years. (6/79)

The gastric acidity of young to elderly Japanese subjects from 1989 to 1999 was assessed and compared with that obtained in 1984, using GA-Test capsules containing acid-dissolving granules of riboflavin. The percentage of achlorhydric subjects increased with age as observed before, however, an over all decrease in all age categories year by year was noted. The percentage of achlorhydric subjects aged 50 years in 1995-1999 was about 40%, which was lower than that (60%) in 1984. However, such a chronological change was not observed when the percentage of achlorhydric subjects was determined according to birth year, indicating that it is related to the birth year of subjects. The percentage of achlorhydric subjects correlated with infection by Helicobacter pylori. Considering the high percentage of achlorhydric elderly, bioavailability and bioequivalence studies should be performed taking into consideration the effects of gastric acidity on the in vivo performance of drug products.  (+info)

Marginal ulcer in achlorhydric patients. (7/79)

Recurrent gastrojejunal ulceration is reported in three patients with histamine-fast achlorhydria. In none of these patients was extruding suture material responsible for the ulceration. However, all three patients had a history of alcohol abuse, and one abused aspirin as well. These cases demonstrate that achlorhydria does not protect against anastomotic ulceration. It is suggested that surgical manipulation produces an increased susceptibility to mucosal damage, and that it is erroneous to consider all anastomotic ulceration as a continuation or recurrence of acid peptic disease.  (+info)

Vagal impairment of gastric secretion in diabetic autonomic neuropathy. (8/79)

Gastric acid output in response to insulin-induced hypoglycaemia and pentagastrin was measured in 18 diabetic patients with symptoms of autonomic neuropathy. Two patients had achlorhydria but the rest responded normally to pentagastrin. The acid output evoked by insulin-induced hypoglycaemia was low in 10 of the 16 patients who secreted acid in response to pentagastrin. These changes suggest that vagal impairment is common in diabetics with autonomic symptoms, which might explain the infrequency of duodenal ulcer in diabetics.  (+info)

Achlorhydria is a medical condition characterized by the absence or near-absence of hydrochloric acid in the stomach. Hydrochloric acid is a digestive fluid that helps to break down food, particularly proteins, and also creates an acidic environment that prevents harmful bacteria from growing in the stomach.

Achlorhydria can be caused by various factors, including certain medications, autoimmune disorders, aging, or surgical removal of the stomach. Symptoms of achlorhydria may include indigestion, bloating, abdominal pain, and malabsorption of nutrients. If left untreated, it can lead to complications such as anemia, vitamin B12 deficiency, and increased risk of gastrointestinal infections.

It is important to note that achlorhydria can be diagnosed through various tests, including a gastric acid analysis or a pH test. Treatment for achlorhydria may involve supplementing with hydrochloric acid or other digestive enzymes, modifying the diet, and addressing any underlying conditions.

Pernicious anemia is a specific type of vitamin B12 deficiency anemia that is caused by a lack of intrinsic factor, a protein made in the stomach that is needed to absorb vitamin B12. The absence of intrinsic factor leads to poor absorption of vitamin B12 from food and results in its deficiency.

Vitamin B12 is essential for the production of healthy red blood cells, which carry oxygen throughout the body. Without enough vitamin B12, the body cannot produce enough red blood cells, leading to anemia. Pernicious anemia typically develops slowly over several years and can cause symptoms such as fatigue, weakness, pale skin, shortness of breath, and a decreased appetite.

Pernicious anemia is an autoimmune disorder, which means that the body's immune system mistakenly attacks healthy cells in the stomach lining, leading to a loss of intrinsic factor production. It is more common in older adults, particularly those over 60 years old, and can also be associated with other autoimmune disorders such as type 1 diabetes, Hashimoto's thyroiditis, and Addison's disease.

Treatment for pernicious anemia typically involves vitamin B12 replacement therapy, either through oral supplements or injections of the vitamin. In some cases, dietary changes may also be recommended to ensure adequate intake of vitamin B12-rich foods such as meat, fish, poultry, and dairy products.

A vipoma, also known as a verner morrison syndrome or a non-insulin-secreting pancreatic tumor, is a rare medical condition characterized by the excessive production and secretion of vasoactive intestinal peptides (VIP) from a functional neuroendocrine tumor in the pancreas. This leads to a series of symptoms known as watery diarrhea, hypokalemia, and acidosis (WDHA) syndrome due to the effects of VIP on the gastrointestinal system. Symptoms include severe watery diarrhea, dehydration, electrolyte imbalances, and low blood pressure. Treatment typically involves surgical removal of the tumor, along with supportive care to manage symptoms and correct electrolyte abnormalities.

Parietal cells, also known as oxyntic cells, are a type of cell found in the gastric glands of the stomach lining. They play a crucial role in digestion by releasing hydrochloric acid and intrinsic factor into the stomach lumen. Hydrochloric acid is essential for breaking down food particles and creating an acidic environment that kills most bacteria, while intrinsic factor is necessary for the absorption of vitamin B12 in the small intestine. Parietal cells are stimulated by histamine, acetylcholine, and gastrin to release their secretory products.

Gastrins are a group of hormones that are produced by G cells in the stomach lining. These hormones play an essential role in regulating gastric acid secretion and motor functions of the gastrointestinal tract. The most well-known gastrin is known as "gastrin-17," which is released into the bloodstream and stimulates the release of hydrochloric acid from parietal cells in the stomach lining.

Gastrins are stored in secretory granules within G cells, and their release is triggered by several factors, including the presence of food in the stomach, gastrin-releasing peptide (GRP), and vagus nerve stimulation. Once released, gastrins bind to specific receptors on parietal cells, leading to an increase in intracellular calcium levels and the activation of enzymes that promote hydrochloric acid secretion.

Abnormalities in gastrin production can lead to several gastrointestinal disorders, including gastrinomas (tumors that produce excessive amounts of gastrin), which can cause severe gastric acid hypersecretion and ulcers. Conversely, a deficiency in gastrin production can result in hypochlorhydria (low stomach acid levels) and impaired digestion.

Zollinger-Ellison Syndrome (ZES) is a rare digestive disorder that is characterized by the development of one or more gastrin-secreting tumors, also known as gastrinomas. These tumors are usually found in the pancreas and duodenum (the first part of the small intestine). Gastrinomas produce excessive amounts of the hormone gastrin, which leads to the overproduction of stomach acid.

The increased stomach acid can cause severe peptic ulcers, often multiple or refractory to treatment, in the duodenum and jejunum (the second part of the small intestine). ZES may also result in diarrhea due to the excess acid irritating the intestines. In some cases, gastrinomas can be malignant and metastasize to other organs such as the liver and lymph nodes.

The diagnosis of Zollinger-Ellison Syndrome typically involves measuring serum gastrin levels and performing a secretin stimulation test. Imaging tests like CT scans, MRI, or endoscopic ultrasounds may be used to locate the tumors. Treatment usually includes medications to reduce stomach acid production (such as proton pump inhibitors) and surgery to remove the gastrinomas when possible.

Gastric juice is a digestive fluid that is produced in the stomach. It is composed of several enzymes, including pepsin, which helps to break down proteins, and gastric amylase, which begins the digestion of carbohydrates. Gastric juice also contains hydrochloric acid, which creates a low pH environment in the stomach that is necessary for the activation of pepsin and the digestion of food. Additionally, gastric juice contains mucus, which helps to protect the lining of the stomach from the damaging effects of the hydrochloric acid. The production of gastric juice is controlled by hormones and the autonomic nervous system.

Gastric acid, also known as stomach acid, is a digestive fluid produced in the stomach. It's primarily composed of hydrochloric acid (HCl), potassium chloride (KCl), and sodium chloride (NaCl). The pH of gastric acid is typically between 1.5 and 3.5, making it a strong acid that helps to break down food by denaturing proteins and activating digestive enzymes.

The production of gastric acid is regulated by the enteric nervous system and several hormones. The primary function of gastric acid is to initiate protein digestion, activate pepsinogen into the active enzyme pepsin, and kill most ingested microorganisms. However, an excess or deficiency in gastric acid secretion can lead to various gastrointestinal disorders such as gastritis, ulcers, and gastroesophageal reflux disease (GERD).

Mucolipidoses are a group of inherited metabolic disorders characterized by the accumulation of complex carbohydrates (muco-) and fatty substances (lipids) in various tissues and cells (-oses). This is due to deficiency in enzymes that help break down these substances within lysosomes, which are organelles responsible for recycling and breaking down waste materials inside the cell.

There are four main types of mucolipidoses (I, II, III, and IV), each resulting from specific genetic mutations affecting different enzymes or proteins involved in the lysosomal degradation pathway. The symptoms, severity, and age of onset can vary widely among these types, ranging from mild to severe and including developmental delays, bone abnormalities, vision and hearing loss, heart problems, and coarse facial features.

Mucolipidoses are typically inherited in an autosomal recessive manner, meaning that an individual must inherit two copies of the mutated gene (one from each parent) to develop the condition. However, mucolipidosis II is caused by X-linked inheritance, where a single copy of the mutated gene on the X chromosome is enough to cause the disorder.

Early diagnosis and management of mucolipidoses can help improve quality of life and slow disease progression. Treatment options include physical therapy, occupational therapy, speech therapy, medications for symptom management, and in some cases, enzyme replacement therapy or bone marrow transplantation.

In anatomical terms, the stomach is a muscular, J-shaped organ located in the upper left portion of the abdomen. It is part of the gastrointestinal tract and plays a crucial role in digestion. The stomach's primary functions include storing food, mixing it with digestive enzymes and hydrochloric acid to break down proteins, and slowly emptying the partially digested food into the small intestine for further absorption of nutrients.

The stomach is divided into several regions, including the cardia (the area nearest the esophagus), the fundus (the upper portion on the left side), the body (the main central part), and the pylorus (the narrowed region leading to the small intestine). The inner lining of the stomach, called the mucosa, is protected by a layer of mucus that prevents the digestive juices from damaging the stomach tissue itself.

In medical contexts, various conditions can affect the stomach, such as gastritis (inflammation of the stomach lining), peptic ulcers (sores in the stomach or duodenum), gastroesophageal reflux disease (GERD), and stomach cancer. Symptoms related to the stomach may include abdominal pain, bloating, nausea, vomiting, heartburn, and difficulty swallowing.

Gastric mucosa refers to the innermost lining of the stomach, which is in contact with the gastric lumen. It is a specialized mucous membrane that consists of epithelial cells, lamina propria, and a thin layer of smooth muscle. The surface epithelium is primarily made up of mucus-secreting cells (goblet cells) and parietal cells, which secrete hydrochloric acid and intrinsic factor, and chief cells, which produce pepsinogen.

The gastric mucosa has several important functions, including protection against self-digestion by the stomach's own digestive enzymes and hydrochloric acid. The mucus layer secreted by the epithelial cells forms a physical barrier that prevents the acidic contents of the stomach from damaging the underlying tissues. Additionally, the bicarbonate ions secreted by the surface epithelial cells help neutralize the acidity in the immediate vicinity of the mucosa.

The gastric mucosa is also responsible for the initial digestion of food through the action of hydrochloric acid and pepsin, an enzyme that breaks down proteins into smaller peptides. The intrinsic factor secreted by parietal cells plays a crucial role in the absorption of vitamin B12 in the small intestine.

The gastric mucosa is constantly exposed to potential damage from various factors, including acid, pepsin, and other digestive enzymes, as well as mechanical stress due to muscle contractions during digestion. To maintain its integrity, the gastric mucosa has a remarkable capacity for self-repair and regeneration. However, chronic exposure to noxious stimuli or certain medical conditions can lead to inflammation, erosions, ulcers, or even cancer of the gastric mucosa.

However, treatment of these disorders has no known effect in the treatment of achlorhydria. Achlorhydria associated with ... Achlorhydria may also be documented by measurements of extremely low levels of pepsinogen A (PgA) (< 17 µg/L) in blood serum. ... Achlorhydria resulting from long-term proton-pump inhibitor (PPI) use may be treated by dose reduction or withdrawal of the PPI ... "Achlorhydria." Medscape. Ed. B S. Anand. N.p., 29 Apr. 2015. Web. 25 May 2015. Kines, Kasia, and Tina Krupczak. "Nutritional ...
First, achlorhydria has been defined by a peak acid output in response to a maximally effective stimulus that results in an ... Achlorhydria, in simple terms, means the absence of hydrochloric acid in gastric secretions and has been defined by multiple ... encoded search term (Achlorhydria) and Achlorhydria What to Read Next on Medscape ... Several conditions associated with achlorhydria lead to increased mortality and morbidity. Specifically, achlorhydria has been ...
Achlorhydria future or investigational therapies. Revision as of 12:42, 4 September 2012 by Kalsang Dolma. (talk , contribs) ( ... American Roentgen Ray Society Images of Achlorhydria future or investigational therapies All Images. X-rays. Echo & Ultrasound ... Created page with __NOTOC__ {{Achlorhydria}} Please help WikiDoc by adding content here. Its easy! Click here to learn about ... Retrieved from "https://www.wikidoc.org/index.php?title=Achlorhydria_future_or_investigational_therapies&oldid=708929" ...
First, achlorhydria has been defined by a peak acid output in response to a maximally effective stimulus that results in an ... Achlorhydria, in simple terms, means the absence of hydrochloric acid in gastric secretions and has been defined by multiple ... encoded search term (Achlorhydria) and Achlorhydria What to Read Next on Medscape ... Achlorhydria Differential Diagnoses. Updated: Apr 29, 2015 * Author: Divyanshoo Rai Kohli, MD; Chief Editor: BS Anand, MD more ...
"Achlorhydria" is a descriptor in the National Library of Medicines controlled vocabulary thesaurus, MeSH (Medical Subject ... This graph shows the total number of publications written about "Achlorhydria" by people in this website by year, and whether " ... Below are the most recent publications written about "Achlorhydria" by people in Profiles. ...
Duchennes, dqo.pkac.mafia.mit.edu.hsv.qm shade spring reheat https://98rockswqrs.com/drugs/zitarax/ https://andrealangforddesigns.com/super-fildena/ https://petermillerfineart.com/nasonex-nasal-spray/ https://postfallsonthego.com/budecort-inhaler/ https://petermillerfineart.com/item/ceftin/ https://mychik.com/innopran-xl/ https://petermillerfineart.com/inderal/ https://ofearthandbeauty.com/product/elimite-cream/ https://weddingadviceuk.com/item/isoniazid/ https://andrealangforddesigns.com/meclizine/ https://98rockswqrs.com/proscalpin/ https://mychik.com/drug/doxycycline/ https://andrealangforddesigns.com/avapro/ https://ofearthandbeauty.com/product/prilox-cream/ https://ma-roots.org/levitra-pack-60/ https://ofearthandbeauty.com/product/man-xxx/ https://mychik.com/drug/p-force/ https://petermillerfineart.com/item/lotrisone/ https://98rockswqrs.com/clindac-a-gel/ https://ofearthandbeauty.com/cialis-oral-jelly/ thrush risk: ,a href=https://98rockswqrs.com/drugs/zitarax/,,/a, ,a ...
Persons at increased risk for infection or more severe disease include infants; the elderly; persons with achlorhydria; those ...
Increased risk of disease with gastric achlorhydria. Theres more to see -- the rest of this topic is available only to ...
Achlorhydria - Problems With Too Little Stomach Acid. Insufficient stomach acid can also cause problems. Stomach acid helps ... Insufficient stomach acid, known as achlorhydria, not only results in poor digestion; it is also associated with lower ...
Multiple endocrine neoplasia (MEN) syndromes are characterized by tumors involving multiple endocrine glands. Subtypes MEN1 and MEN2 are distinguished by clinical features and molecular testing. MEN2 includes the additional subtypes MEN2A, MEN2B, and familial medullary thyroid carcinoma (FMTC).
... in patients who have achlorhydria (119), ileus, or upper gastrointestinal disease; and in patients receiving enteral feeding, ...
Achlorhydria syndrome. Diabetic diarrhea. * Adverse Effects: octreotide * Gastrointestinal disturbances. * Biliary sludge; ...
Plummer-Vinson syndrome (achlorhydria; iron deficiency anemia; and mucosal atrophy of the mouth, pharynx, and esophagus) has ...
Patients with achlorhydria should take RESCRIPTOR with an acidic beverage (e.g., orange or cranberry juice). However, the ... Patients with achlorhydria should take RESCRIPTOR with an acidic beverage (e.g., orange or cranberry juice). However, the ... effect of an acidic beverage on the absorption of delavirdine in patients with achlorhydria has not been investigated. ... effect of an acidic beverage on the absorption of delavirdine in patients with achlorhydria has not been investigated. ...
Effect of gastrin receptor blockade on endocrine cells in rats during achlorhydria. Gastroenterology 103:1596-1601. ...
Other signs are constipation, ascites, achlorhydria and pernicious anemia.. *Diagnostic signs. They include anemia, bradycardia ...
tell your doctor if you have or have ever had achlorhydria (condition in which stomach has little or no acid) or liver or ... tell you to take delavirdine tablets with orange or cranberry juice if you have certain medical conditions such as achlorhydria ...
It may help people with hypochlorhydria (low stomach acid) or achlorhydria (no stomach acid). ...
For this reason infants and patients with hypo- or achlorhydria and/or stomach lesions are to be considered as special risk ...
Patients with pernicious anemia usually have very low levels of hydrochloric acid in the stomach (achlorhydria) and high levels ... But atrophic gastritis is absent, so achlorhydria, parietal cell antibodies or IF antibodies are absent. Intrinsic factor ... so are features of pernicious anemia like achlorhydria, antibodies and normal IF levels. ...
If you have an absence of acid in your stomach caused by a condition called achlorhydria; ...
Doscherholmen A, Swaim WR. Impaired assimilation of egg Co57 -vitamin B12 in patients with hypochlorhydria and achlorhydria and ...
Intrinsic factors include an abnormality in the mucosal defense, such as achlorhydria, impairment of intestinal motility, and ...
For patients with achlorhydria, administration with an acidic beverage (i.e., cola) significantly increases the oral ...
Mice homozygous for a knock-down allele exhibit growth retardation, partial postnatal lethality, achlorhydria, and abnormal ...
... in contrast to the relative achlorhydria invariably observed in true pernicious anemia. ...
... effects of anticholinergic drugs on gastric hydrochloric acid secretion are antagonized by agents used to treat achlorhydria ...
... achlorhydria), low levels of bile, untreated phosphate imbalance.Chewable tablets may contain sugar or aspartame. Caution is ...

No FAQ available that match "achlorhydria"

No images available that match "achlorhydria"